Bosutinib - related pleural effusion in patients with chronic myeloid leukemia

Expert Opin Drug Saf. 2021 Apr;20(4):379-381. doi: 10.1080/14740338.2021.1867103. Epub 2021 Jan 8.

Authors

Mebrure Burçak Yüzbaşıoğlu¹, Ahmet Emre Eşkazan²

Affiliations

¹ Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.
² Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Turkey.

PMID: 33339467
DOI: 10.1080/14740338.2021.1867103

No abstract available

Keywords: Adverse event; bosutinib; chronic myeloid leukemia; pleural effusion; tyrosine kinase inhibitor.

Publication types

Editorial

MeSH terms

Aniline Compounds / administration & dosage
Aniline Compounds / adverse effects*
Antineoplastic Agents / administration & dosage
Antineoplastic Agents / adverse effects
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
Nitriles / administration & dosage
Nitriles / adverse effects*
Pleural Effusion / chemically induced*
Protein Kinase Inhibitors / administration & dosage
Protein Kinase Inhibitors / adverse effects*
Quinolines / administration & dosage
Quinolines / adverse effects*

Substances

Aniline Compounds
Antineoplastic Agents
Nitriles
Protein Kinase Inhibitors
Quinolines
bosutinib